INS and diabetes mellitus: The conducted quantitative assessment of adiponectin indicated a significantly lower concentration of this adipocytokine in the blood plasma in individuals suffering from diabetes—before treatment, in relation to its concentration in the healthy individuals’ blood plasma as well as in those subject to insulin therapy.